913375-89-0 Usage
Class
Pyrazole derivatives 1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carbaldehyde belongs to a group of chemically related molecules that are derived from the pyrazole structure.
Pyridine ring
A six-membered aromatic ring with one nitrogen atom replacing one carbon atom in a benzene ring.
Phenyl group
A six-membered aromatic ring with delocalized electrons, attached to the pyridine ring.
Carbaldehyde functional group
A carbonyl group (C=O) bonded to a hydrogen atom and an alkyl or aryl group.
Complexity
Complex organic compound This indicates that the compound has a relatively large and intricate molecular structure.
Applications
Chemical research and pharmaceuticals The compound is commonly used in these fields, potentially for drug development and various biological activities.
Pharmacological properties
May exhibit various biological activities This suggests that the compound could have multiple effects on biological systems, making it a potential candidate for drug development.
Reactivity
Varies depending on specific properties The compound's reactivity with other substances may change based on its unique characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 913375-89-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,3,7 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 913375-89:
(8*9)+(7*1)+(6*3)+(5*3)+(4*7)+(3*5)+(2*8)+(1*9)=180
180 % 10 = 0
So 913375-89-0 is a valid CAS Registry Number.
913375-89-0Relevant academic research and scientific papers
Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series
Liu, Longbin,Norman, Mark H.,Lee, Matthew,Xi, Ning,Siegmund, Aaron,Boezio, Alessandro A.,Booker, Shon,Choquette, Debbie,D'Angelo, Noel D.,Germain, Julie,Yang, Kevin,Yang, Yajing,Zhang, Yihong,Bellon, Steven F.,Whittington, Douglas A.,Harmange, Jean-Christophe,Dominguez, Celia,Kim, Tae-Seong,Dussault, Isabelle
experimental part, p. 1868 - 1897 (2012/05/04)
As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2- phenyl-2,3-dihydro-1H-pyrazole-4-c
SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS
-
, (2008/06/13)
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
